K2M Acquires Expandable Interbody IP Portfolio

K2M acquired exclusive license to a portfolio of 17 issued and pending patents for expandable interbody fusion devices (IBFs), which will support development of new products using Lamellar 3D Titanium Technology™.

K2M expects the IP will yield devices with greater expansion capabilities than many available today.

The company is already...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0